technetium tc 99m hydroxymethylene diphosphonate has been researched along with etidronate in 10 studies
| Studies (technetium tc 99m hydroxymethylene diphosphonate) | Trials (technetium tc 99m hydroxymethylene diphosphonate) | Recent Studies (post-2010) (technetium tc 99m hydroxymethylene diphosphonate) | Studies (etidronate) | Trials (etidronate) | Recent Studies (post-2010) (etidronate) |
|---|---|---|---|---|---|
| 618 | 35 | 87 | 2,819 | 510 | 432 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 2 (20.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| de Jonge, FA; Hamdy, NA; Pauwels, EK | 1 |
| Coffey, JL; London, J; Makler, PT; Thomas, SR; Watson, EE; Weber, DA | 1 |
| Fogelman, I | 1 |
| Barnett, BL; Benedict, JJ; Bevan, JA; Francis, MD; Tofe, AJ | 2 |
| Bevan, JA; Ferguson, DL; Francis, MD; Michaels, SE; Tofe, AJ | 1 |
| Alvarez, L; de Osaba, MJ; Guañabens, N; Monegal, A; Parés, A; Peris, P; Pons, F; Roca, M; Rodés, J; Torra, M | 1 |
| Franke, WG; Hliscs, R; Kropp, J; Liepe, K | 1 |
| Brenner, W; Brümmer, C; Czech, N; Henze, E; Kampen, WU; Muhle, C; von Forstner, C; Zuhayra, M | 1 |
| Alsharif, A; Boni, G; Borsò, E; Chiacchio, S; Greco, C; Grosso, M; Lorenzoni, A; Manca, G; Mariani, G; Mazzarri, S; Nyakale, N; Volterrani, D | 1 |
2 review(s) available for technetium tc 99m hydroxymethylene diphosphonate and etidronate
| Article | Year |
|---|---|
Scintigraphy in the clinical evaluation of disorders of mineral and skeletal metabolism in renal failure.
Topics: Amyloidosis; Calcinosis; Chronic Kidney Disease-Mineral and Bone Disorder; Etidronic Acid; Humans; Kidney Failure, Chronic; Organotechnetium Compounds; Radionuclide Imaging; Renal Dialysis; Technetium Tc 99m Medronate | 1991 |
Radionuclide therapy and integrated protocols for bone metastases.
Topics: Bone Neoplasms; Combined Modality Therapy; Diphosphonates; Drug Therapy, Combination; Etidronic Acid; Humans; Organometallic Compounds; Organophosphorus Compounds; Pain; Palliative Care; Patient Selection; Radioimmunotherapy; Radiopharmaceuticals; Technetium Tc 99m Medronate; Treatment Outcome | 2011 |
1 trial(s) available for technetium tc 99m hydroxymethylene diphosphonate and etidronate
| Article | Year |
|---|---|
Etidronate versus fluoride for treatment of osteopenia in primary biliary cirrhosis: preliminary results after 2 years.
Topics: Absorptiometry, Photon; Bone Density; Bone Diseases, Metabolic; Drug Administration Schedule; Etidronic Acid; Female; Femur; Follow-Up Studies; Humans; Liver Cirrhosis, Biliary; Lumbar Vertebrae; Middle Aged; Radionuclide Imaging; Radiopharmaceuticals; Sodium Fluoride; Technetium Tc 99m Medronate; Time Factors | 1997 |
7 other study(ies) available for technetium tc 99m hydroxymethylene diphosphonate and etidronate
| Article | Year |
|---|---|
Radiation absorbed dose from technetium-99m-labeled bone imaging agents. Task Group of the Medical Internal Radiation Dose Committee, The Society of Nuclear Medicine.
Topics: Bone and Bones; Diphosphates; Etidronic Acid; Humans; Organotechnetium Compounds; Radiation Dosage; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate | 1989 |
Diphosphonate bone scanning agents--current concepts.
Topics: Bone Diseases; Bone Neoplasms; Diphosphonates; Etidronic Acid; Humans; Organotechnetium Compounds; Radionuclide Imaging; Technetium; Technetium Tc 99m Medronate | 1982 |
Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Topics: Acute Disease; Animals; Bone and Bones; Diphosphates; Diphosphonates; Dogs; Etidronic Acid; Guinea Pigs; Injections, Intravenous; Myocardial Infarction; Organotechnetium Compounds; Radionuclide Imaging; Rats; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate; Time Factors; Tissue Distribution | 1980 |
Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Topics: Animals; Bone and Bones; Diphosphates; Diphosphonates; Dogs; Dose-Response Relationship, Drug; Etidronic Acid; Femur; Myocardial Infarction; Organotechnetium Compounds; Radionuclide Imaging; Ribs; Technetium; Technetium Tc 99m Medronate; Technetium Tc 99m Pyrophosphate; Tissue Distribution | 1980 |
Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Topics: Adsorption; Animals; Bone and Bones; Calcium Phosphates; Chemical Phenomena; Chemistry; Diphosphonates; Etidronic Acid; Hydroxyapatites; Organotechnetium Compounds; Osteogenesis; Radionuclide Imaging; Rats; Technetium; Technetium Tc 99m Medronate; Time Factors; Tin; Tissue Distribution | 1980 |
Significant reduction of the mass of bone metastasis 1 year after rhenium-186 HEDP pain palliation therapy.
Topics: Bone Neoplasms; Etidronic Acid; Humans; Male; Middle Aged; Organometallic Compounds; Pain; Palliative Care; Prostatic Neoplasms; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate | 2000 |
Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Topics: Animals; Bone and Bones; Connective Tissue; Etidronic Acid; Female; Organometallic Compounds; Organophosphorus Compounds; Rabbits; Radionuclide Imaging; Radiopharmaceuticals; Rhenium; Technetium Tc 99m Medronate; Urinary Bladder; Whole-Body Counting | 2003 |